研究成果 ( Publications) 

A.期刊論文 Refereed Papers

1. Kuo HY, Chang WL, Yeh YC, Tsai YC, Wu CT, Cheng HC, Yang HB, Lu CC, Sheu BS*.2017, February. Serum level of trefoil factor 2 can predict the extent of gastric spasmolytic polypeptide-expressing metaplasia in the H. pylori-infected gastric cancer relatives. Helicobacter 22(1):e12320.doi: 10.1111/hel.12320, Hoboken, NJ, USA. (2021 SCI, IF=5.182;原著論文)(34/93, GASTROENTEROLOGY & HEPATOLOGY; 48/136, MICROBIOLOGY)
2. Sheu BS, Wu MS, Chiu CT, Lo JC, Wu DC, Liou JM, Wu CY, Cheng HC, Lee YC, Hsu PI, Chang CC, Chang WL, Lin JT*. 2017, June. Consensus on the clinical management, screening-to-treat, and surveillance of H. pylori infection to improve gastric cancer control on a nationwide scale. Helicobacter 22(3):e12368.doi: 10.1111/hel.12368, Hoboken, NJ, USA. (2021 SCI, IF=5.182;原著論文)(34/93, GASTROENTEROLOGY & HEPATOLOGY; 48/136, MICROBIOLOGY)
3. Chang WL, Lin MY, Kuo HY, Yang HB, Cheng HC, Lu CC, Sheu BS*. 2017, July. Osteopontin polymorphism increases gastric precancerous intestinal metaplasia susceptibility in Helicobacter pylori infected male. Future Oncol 13(16):1415-1425, London, England. (2021 SCI, IF=3.674;原著論文)(149/245, ONCOLOGY)
4. Cheng HC, Tsai YC, Yang HB, Yeh YC, Chang WL, Kuo HY, Lu CC, Sheu BS*. 2017, August. The corpus-predominant gastritis index can be an early and reversible marker to identify the gastric cancer risk of Helicobacter pylori-infected nonulcer dyspepsia. Helicobacter 22(4):e12385. doi: 10.1111/hel.12385, Hoboken, NJ, USA. (2021 SCI, IF=5.182;原著論文)(34/93, GASTROENTEROLOGY & HEPATOLOGY; 48/136, MICROBIOLOGY)
5. Yang YJ, Wu CT, Ou HY, Lin CH, Cheng HC, Chang WL, Chen WY, Yang HB, Lu CC, Sheu BS*. 2017, September. Ten days of levofloxacin-containing concomitant therapy can achieve effective Helicobacter pylori eradication in patients with type 2 diabetes. Ann Med 49(6):479-486, Oxon, England. (2021 SCI, IF=5.348;原著論文)(47/172, MEDICINE, GENERAL & INTERNAL)
6. Yang YJ, Wu CT, Ou HY, Lin CH, Cheng HC, Chang WL, Chen WY, Yang HB, Lu CC, Sheu BS*. 2017, October. Male non-insulin users with type 2 diabetes mellitus are predisposed to gastric corpus-predominant inflammation after H. pylori infection. J Biomed Sci 24(1):82, London, England. (2021 SCI, IF=12.771;原著論文)(24/194, CELL BIOLOGY; 11/139, MEDICINE, RESEARCH & EXPERIMENTAL)
7. Yang EH, Cheng HC, Wu CT, Chen WY, Lin MY, Sheu BS*. 2018, January. Peptic ulcer bleeding patients with Rockall scores ≥6 are at risk of long-term ulcer rebleeding: A 3.5-year prospective longitudinal study. J Gastroenterol Hepatol 33(1):156-163, Hoboken, NJ, USA. (2021 SCI, IF=4.369;原著論文)(43/93, GASTROENTEROLOGY & HEPATOLOGY) (The contribution of Dr. Cheng HC is equal to that of the first author)
8. Cheng HC, Sheu BS*. 2018, March. Reply to “Hypoalbuminemia is a predictor of mortality and rebleeding in peptic ulcer bleeding under proton pump inhibitor use: Methodological issues.” J Formos Med Assoc 117(3):252-253, Taipei, Taiwan. (2021 SCI, IF=3.871; Reply)(61/172, MEDICINE, GENERAL & INTERNAL)
9. Cheng HC, Yang EH, Wu CT, Wang WL, Chen PJ, Lin MY, Sheu BS*. 2018, April. Hypoalbuminemia is a predictor of mortality and rebleeding in peptic ulcer bleeding under proton pump inhibitor use. J Formos Med Assoc 117(4):316-325, Taipei, Taiwan. (2021 SCI, IF=3.871;原著論文)(61/172, MEDICINE, GENERAL & INTERNAL)
10. Liou JM, Sheu BS*, Lee YC, Cheng HC, Chang WL, Wu DC, Hsu PI, Wu CY, Wu MS, Chiu CT, Lin JT*. 2018, May. Survey of the adherence to the consensus of gastroesophageal reflux disease before and after the implementation course. J Formos Med Assoc 117(5):440-449, Taipei, Taiwan. (2021 SCI, IF=3.871;原著論文)(61/172, MEDICINE, GENERAL & INTERNAL)
11. Cheng HC, Liou JM, Luo JC, Chiu CT, Wu MS, Lee YC, Wu CY, Wu DC, Hsu PI, Chang CC, Chang WL, Lin JT*, Sheu BS*. 2018, October. The implementation of the consensus on the management of Helicobacter pylori and barriers to consensus. Helicobacter 23 (5):e12533. doi: 10.1111/hel.12533, Hoboken, NJ, USA (2021 SCI, IF=5.182;原著論文)(34/93, GASTROENTEROLOGY & HEPATOLOGY; 48/136, MICROBIOLOGY) (The contribution of Dr. Liou JM is equal to that of the first author)
12. Yeh YC, Kuo HY, Chang WL, Yang HB, Lu CC, Cheng HC*, Wu MS*, Sheu BS*. 2019, January. H. pylori isolates with amino acid sequence polymorphisms as presence of both HtrA-L171 & CagL-Y58/E59 increase the risk of gastric cancer. J Biomed Sci 26(1):4, London, England. (2021 SCI, IF=12.771;原著論文)(24/194, CELL BIOLOGY; 11/139, MEDICINE, RESEARCH & EXPERIMENTAL) (The contribution of Dr. Cheng HC and Dr. Wu MS is equal to that of the corresponding author)
13. Chien SC, Chen CY, Cheng PN, Liu YS, Cheng HC, Chuang CH, Chang TT, Chiu HC, Lin YJ, Chiu YC*. 2019, May. Combined transarterial embolization/ chemoembolization-based locoregional treatment with Sorafenib prolongs the survival in patients with advanced hepatocellular carcinoma and preserved liver function: a propensity score matching study. Liver cancer 8 (3): 186-202, Basel, Switzerland. (2021 SCI, IF=12.430;原著論文)(8/93, GASTROENTEROLOGY & HEPATOLOGY; 26/245, ONCOLOGY)
14. Kuo HY, Chang WL, Yeh YC, Cheng HC, Tsai YC, Wu CT, Lin SH, Yang HB, Lu CC, Sheu BS*. 2019, June. Spasmolytic polypeptide-expressing metaplasia associated with higher expressions of miR-21, 155, and 223 can be regressed by Helicobacter pylori eradication in the gastric cancer familial relatives. Helicobacter 24 (3):e12578. doi: 10.1111/hel.12578, Hoboken, NJ, USA. (2021 SCI, IF=5.182;原著論文)(34/93, GASTROENTEROLOGY & HEPATOLOGY; 48/136, MICROBIOLOGY)
15. Chen WY, Cheng HC, Cheng WC, Wang JD, Sheu BS*. 2019, September. Lead time bias may contribute to the shorter life expectancy in post-colonoscopy colorectal cancer. Dig Dis Sci 64 (9): 2622-2630, Dordrecht, Netherlands. (2021 SCI, IF=3.487;原著論文)(57/93, GASTROENTEROLOGY & HEPATOLOGY)
16. Yang EH, Wu CT, Kuo HY, Chen WY, Sheu BS*, Cheng HC*. 2020, April. The recurrent bleeding risk of a Forrest IIc lesion at the second-look endoscopy can be indicated by high Rockall scores ≥6. Surg Endosc 34 (4): 1592-1601, New York, NY, USA. (The contribution of Dr. Sheu BS is equal to that of the corresponding author) (2021 SCI, IF=3.453;原著論文)(60/211, SURGERY)
17. Chen CT, Chen YC, Chen JR, Lee HF, Cheng HC*. 2019, December. 以積極乳酸林格氏輸液預防內視鏡逆行性膽胰管攝影術後胰臟炎發生之照護Aggressive hydration with Lactated Ringer’s solution for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. 台灣專科護理師學刊Journal of Taiwan Nurse Practitioners 6:44-54.
18. Hsieh MT, Chang WL, Wu CT, Yang HB, Kuo HY. Lin MY, Cheng HC, Tsai YC, Sheu BS*. 2020, June. Optimizing the MIC breakpoints of amoxicillin and tetracycline for antibiotic selection in the rescue therapy of H. pylori with bismuth quadruple regimen. Eur J Clin Pharmacol https://doi.org/10.1007/s00228-020-02938-5 (2021 SCI, IF=3.064;原著論文)(174/279, PHARMACOLOGY & PHARMACY).
19. Liou JM, Malfertheiner P, Lee YC, Sheu BS, Sugano K, Cheng HC, Guan YK, Hsu PI, Go KL, Mahachai V, Gotoda T, Chang WL, Chen MJ, Chiang TH, Chen CC, Wu CY, Leow AH, Wu JY, Wu DC, Hong TC, Lu H, Yamaoka Y, Mégraud F, Chan FK, Sung JJ, Lin JT, Graham DY, El-Omar EM, Wu MS*, Asian Pacific Alliance on Helicobacter and Microbiota (APAHAM). 2020, December. Screening and eradication of Helicobacter pylori for gastric cancer prevention-the Taipei global consensus. Gut 69:2093-2112. (2021 SCI, IF=31.840;原著論文)(4/93, GASTROENTEROLOGY & HEPATOLOGY)
20. Lin TH, Jhang JY, Huang CR*, Tsai YC, Cheng HC, Sheu BS. 2021, January. Deep ensemble feature network for gastric section classification. IEEE J Biomed Health Inform 2021; 25(1):77-87. (MOST107-2221-E-005-065-MY2, MOST107-2314-B-006-021-MY3 and MOST105-2314-B-006-015-MY3) (2021 SCI, IF=7.021;原著論文)(23/164, COMPUTER SCIENCE, INFORMATION SYSTEMS; 21/113 COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS; 4/57 MATHEMATICAL & COMPUTATIONAL BIOLOGY; 7/31 MEDICAL INFORMATICS).
21. Cheng HC*. 2021, July. Genetic variation of innate immune response and inflammation in susceptibility to Helicobacter pylori-related diseases. Adv Dig Med 2021; 8:136-138. (2021 SCI, JCI=0.04; editorial)(129/135, GASTROENTEROLOGY & HEPATOLOGY, rank by JCI)
22. Hu FW, Yeh CY, Huang CC, Cheng HC, Lin CH, Chang CM*. A novel intervention to reduce noninfectious and infectious complications associated with indwelling urethral catheters in hospitalized older patients: a quasi-experimental study. BMC Geriatr 2022; 22:426. (2021 SCI, IF=4.076;原著論文)(28/54, GERIATRICS & GERONTOLOGY; 10/37 GERONTOLOGY)
23. Chou KY, Chen WY, Cheng HC, Cheng CL*. Short-term intra-arterial vasopressin infusion as rescue treatment for small-bowel bleeding with severe thrombocytopenia. Br J Hosp Med (accept) 2022. (2021 SCI, IF=1.286;原著論文)(138/172, MEDICINE, GENERAL & INTERNAL)
24. Chiang TH, Cheng HC, Chuang SL, Chen YR, Hsu YH, Hsu TH, Lin LJ, Lin YW, Chu CH, Wu MS, Lee YC*. Mass screening and eradication of Helicobacter pylori as the policy recommendations for gastric cancer prevention. J Formos Med Assoc (accept) 2022. (2021 SCI, IF=3.871;原著論文)(61/172, MEDICINE, GENERAL & INTERNAL)
25. Chiang HC, Yang EH, Hu HM, Chen WY, Chang WL, Wu CT, Wu DC, Sheu BS, Cheng HC*. An extended 36-week oral esomeprazole improved long-term recurrent peptic ulcer bleeding in patients at high risk of rebleeding. BMC Gastroenterol 2022; 22:439 (2021 SCI, IF=2.848;原著論文)(73/93, GASTROENTEROLOGY & HEPATOLOGY)
26. Cheng HC*, Yang YJ, Yang HB, Tsai YC, Chang WL, Wu CT, Kuo HY, Yu YT, Yang EH, Cheng WC, Chen WY, Sheu BS. Evolution of the Correa’s cascade steps: a long-term endoscopic surveillance among non-ulcer dyspepsia and gastric ulcer after H. pylori eradication. J Formos Med Assoc (accept) 2022. (2021 SCI, IF=3.871;原著論文)(61/172, MEDICINE, GENERAL & INTERNAL)

B. 研討會論文 Conference papers

1. 張夢馨，張家銘，游詠晨，胡芳文，林峻宇，鄭修琦，施欣怡，楊登棋。社區老人疑似疏忽照顧初探­-以某醫學中心內科病房為例。社團法人台灣高齡照護暨教育協會106年會員大會暨學術研討會，台灣台南。
2. Wang YS, Ni JY, Huang WC, Cheng HC, Chen CY. Repeated manual cleaning and modified manual cleaning with ultrasonic oscillator could improve the cleaning of duodenoscopes after endoscopic procedures. Posters of distinction awards in 2018 Taiwan Digestive Disease Week, Taipei, Taiwan.
3. Lin TH, Huang CR, Cheng HC, Sheu BS. Gastric section detection based on decision fusion of convolutional neural networks. Poster presentation at the 2019 IEEE Biomedical Circuits and Systems Conference, Nara, Japan. IEEE BIOCAS 2019 (https://biocas2019.org/ ).
4. Cheng HC, Tsai YC, Wu CT, Yang EH, Kuo HY, Chang WL, Chen WY, Cheng WC, Yang HB, Sheu BS. Corpus-predominant gastritis index (CGI) could be regressed after successful H. pylori eradication among H. pylori-infected non-ulcer dyspepsia and gastric ulcer patients. Oral presentation at the 10^th Asian Pacific Topic Conference 2019, Kaohsiung, Taiwan. Posters of distinction awards in the 10^th Asian Pacific Topic Conference 2019.
5. Cheng HC, Tsai YC, Wu CT, Yang EH, Kuo HY, Chang WL, Chen WY, Cheng WC, Yang HB, Sheu BS. Helicobacter pylori ImaA polymorphisms can determine the increased host gastric integrin α5β1 expression and gastric cancer risk. Poster presentation at the 10^th Asian Pacific Topic Conference 2019, Kaohsiung, Taiwan.
6. Kuo HY, Tseng TC, Cheng HC, Chang WL, Yang HB, Lu CC, Sheu BS. The identification of genetic susceptibility to gastric intestinal metaplasia in high risk gastric cancer family member by GWAS study. Poster presentation at the 10^th Asian Pacific Topic Conference 2019, Kaohsiung, Taiwan.
7. Hsieh MT, Chang WL, Wu CT, Yang HB, Kuo HY, Lin MY, Cheng HC, Tsai YC, Sheu BS. Establish the MIC breakpoints of amoxicillin and tetracycline resistance in triple-drug resistant H. pylori as the guide of rescue therapy. Oral presentation at the 10^th Asian Pacific Topic Conference 2019, Kaohsiung, Taiwan. Posters of distinction awards in the 10^th Asian Pacific Topic Conference 2019.
8. Tsai YC, Yang HB, Kuo HY, Cheng HC, Chang WL, Hsieh MT, Lu CC, Sheu BS. Combined corpus predominant gastritis index (CGI) and intestinal metaplasia expand coverage of gastric cancer risk determination. Poster presentation at the 10^th Asian Pacific Topic Conference 2019, Kaohsiung, Taiwan.
9. Cheng WC, Chen WY, Chen PJ, Lin MY, Cheng HC, Chang WL, Wu CT, Tsai YC, Yang EH, Kuo HY, Shue BS. Risk factors determining the detection of advanced colorectal neoplasia in patients with negative fecal immunochemical test. Oral presentation in 2019 Taiwan Digestive Disease Week, Kaohsiung, Taiwan.
10. Wu CT, Cheng HC, Chen WY, Yang EH, Lin MY, Hsieh MT, Chang WL, Tsai YC, Yang HB, Yang YJ, Lu CC, Sheu BS. Amoxicillin susceptibility can determine the eradication rate of bismuth-containing rifabutin-based rescue regimen in refractory H. pylori infection. Poster presentation in 2019 Taiwan Digestive Disease Week, Kaohsiung, Taiwan.
11. Cheng HC, Yang HB, Wu CT, Chang WL, Chen WY, Tsai YC, Sheu BS. The amino acid polymorphisms of ImaA of H. pylori correlated to host gastric mucosal integrin a5b1 expression and the development of OLGA and OLGIM stages III-IV. Poster presentation in 2020 Taiwan Digestive Disease Week, Taipei, Taiwan.
12. Chiang HC, Yang EH, Chen WY, Chang WL, Hu HM, Tsai YC, Cheng WC, Wu CT, Wu DC, Sheu BS, Cheng HC. Randomised clinical trial: a 36-week oral esomeprazole 20 mg twice daily versus once daily or controls after an initial 16-week proton pump inhibitor treatment for long-term recurrent peptic ulcer bleeding in patients with Rockall scores ³6. Oral presentation in 2021 Taiwan Digestive Disease Week, online, Taiwan.
13. Nien CM, Yang EH, Chang WL, Cheng HC, Huang CR. Criss-cross attention based multi-level fusion network for gastric intestinal metaplasia segmentation. MICCAI 2022; 25^th International Conference on Medical Image Computing and Computer Assisted Intervention. Sep 18-22, 2022, Singapore.
14. Tsai YC, Yang HB, Chang WL, Kuo HY, Wu TC, Lin MY, Yang EH, Hsieh MT, Lee CT, Yu YT, Cheng HC. The narrow band image (NBI) endoscopy images were associated with the presentations of gastric precancerous lesions in patients with maintenance use of proton pump inhibitor. Poster presentation in 2022 Taiwan Digestive Disease Week, Taipei, Taiwan.